cilostazol has been researched along with Colorectal Neoplasms in 1 studies
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strowitzki, MJ | 1 |
| Dold, S | 1 |
| von Heesen, M | 1 |
| Körbel, C | 1 |
| Scheuer, C | 1 |
| Moussavian, MR | 1 |
| Schilling, MK | 1 |
| Kollmar, O | 1 |
| Menger, MD | 1 |
1 other study available for cilostazol and Colorectal Neoplasms
| Article | Year |
|---|---|
The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy.
Topics: Animals; Apoptosis; Cell Proliferation; Cilostazol; Colorectal Neoplasms; Exonucleases; Female; Hepa | 2014 |